INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and mosunetuzumab, with ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

In addition to the new NSF grant, the company has raised a $1.9M pre-seed round from 2048.vc, The Venture Collective (TVC), Pioneer Fund, and Portland Seed Fund, and secured a $275k Phase I NSF SBIR ...

Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME ...

The University of Maryland has received $51.7 million in new philanthropic investments from its most generous benefactor, the A. James & Alice B. Clark Foundation, to dramatically expand scholarships ...

On Saturdays, Linda Hoersten checks to see which of her students are failing a class, then she makes a call home to notify ...

Zinia Khattar, a Del Norte High graduate who is attending Harvard University, received a $50,000 scholarship as a Davidson ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...